Read More Pharma Industry News PIPE-505 : Pipeline Therapeutics initiates phase 1/2a SNHL trial Pipeline Therapeutics has initiated a phase 1/2a trial of PIPE-505, which is a small molecule gamma secretase inhibitor… bypharmanewsdailyJuly 26, 2020